The Intrauterine Device in Women with Diabetes Mellitus Type I and II: A Systematic Review.

Norman D Goldstuck, Petrus S Steyn
{"title":"The Intrauterine Device in Women with Diabetes Mellitus Type I and II: A Systematic Review.","authors":"Norman D Goldstuck, Petrus S Steyn","doi":"10.1155/2013/814062","DOIUrl":null,"url":null,"abstract":"<p><p>Background. Women with diabetes mellitus type I and type II need effective contraception for personal and medical reasons. Long acting reversible contraceptive (LARC) methods are among the most efficient and cost-effective methods. Study Design. We searched the Popline, PubMed, and clinicaltrials.gov databases from 1961 to March 2013 for studies on the efficacy of the IUD in diabetic women and the possible changes it may produce in laboratory parameters. Studies of at least 30 subjects with DM1 or DM2 who were studied for 6 to 12 months depending on the method of analysis were eligible. Results. The search produced seven articles which gave event rate efficacy evaluable results and three which evaluated the effect of the IUD on laboratory parameters. One of the earlier efficacy studies showed an abnormally high pregnancy rate which sparked a controversy which is discussed in the Introduction section. The remaining 6 studies produced acceptable pregnancy rates. The three laboratory studies showed that the copper and levonorgestrel releasing IUD/IUS do not affect the diabetic state in any way. Conclusions. The copper bearing and levonorgestrel releasing IUDs are safe and effective in women with diabetes type I and diabetes type II although the evidence in the latter is limited. </p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":"2013 ","pages":"814062"},"PeriodicalIF":0.0000,"publicationDate":"2013-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874344/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN obstetrics and gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2013/814062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background. Women with diabetes mellitus type I and type II need effective contraception for personal and medical reasons. Long acting reversible contraceptive (LARC) methods are among the most efficient and cost-effective methods. Study Design. We searched the Popline, PubMed, and clinicaltrials.gov databases from 1961 to March 2013 for studies on the efficacy of the IUD in diabetic women and the possible changes it may produce in laboratory parameters. Studies of at least 30 subjects with DM1 or DM2 who were studied for 6 to 12 months depending on the method of analysis were eligible. Results. The search produced seven articles which gave event rate efficacy evaluable results and three which evaluated the effect of the IUD on laboratory parameters. One of the earlier efficacy studies showed an abnormally high pregnancy rate which sparked a controversy which is discussed in the Introduction section. The remaining 6 studies produced acceptable pregnancy rates. The three laboratory studies showed that the copper and levonorgestrel releasing IUD/IUS do not affect the diabetic state in any way. Conclusions. The copper bearing and levonorgestrel releasing IUDs are safe and effective in women with diabetes type I and diabetes type II although the evidence in the latter is limited.

Abstract Image

宫内节育器在 I 型和 II 型糖尿病妇女中的应用:系统综述。
背景。出于个人和医疗原因,患有 I 型和 II 型糖尿病的妇女需要采取有效的避孕措施。长效可逆避孕法(LARC)是最有效、最经济的避孕方法之一。研究设计。我们检索了 1961 年至 2013 年 3 月期间的 Popline、PubMed 和 clinicaltrials.gov 数据库,以了解有关宫内节育器对糖尿病妇女的疗效及其可能对实验室参数产生的变化的研究。根据分析方法的不同,至少有 30 名患有 DM1 或 DM2 的受试者接受了 6 至 12 个月的研究。结果。搜索结果显示,有七篇文章提供了可评估的事件发生率疗效结果,有三篇文章评估了宫内节育器对实验室参数的影响。其中一项早期疗效研究显示了异常高的妊娠率,引发了争议,这将在导言部分进行讨论。其余 6 项研究的妊娠率均可接受。三项实验室研究表明,释放铜和左炔诺孕酮的宫内节育器/宫内植入物对糖尿病患者没有任何影响。结论。含铜和左炔诺孕酮释放型宫内节育器对Ⅰ型和Ⅱ型糖尿病妇女是安全有效的,但后者的证据有限。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信